BB's Stock Haven

[threebabiesbusy]

MIVT: Six Month Target Price just raised to $2.50...
MIV Therapeutics' Six-Month Share Price Target Raised 100% to $2.50 in Newly Available Report from SISM Research
Friday September 30, 3:30 am ET
Increased Target Reflects MIVT's Progress in Biocompatible Drug Delivery and Coating Development, Maintains Speculative Buy/4 Rating


VANCOUVER, British Columbia--(BUSINESS WIRE)--Sept. 30, 2005--MIV Therapeutics, Inc. (OTCBB:MIVT - News; Frankfurt/FSE:MIV), a developer of next-generation biocompatible stent coatings and drug delivery technologies, announced the availability of a new research report targeting the Company's six-month share price at $2.50, an approximate doubling of the recent share value, with a speculative Buy/4 Rating. The report was issued by SISM Research and Investment Services.



Web Alert: Biophan Technologies, MIV Therapeutics and Xenomics to Present at Trilogy Capital's Biotechnology Forum Tues., Oct. 11th at 12:00 noon -ET-
Monday October 3, 3:30 am ET


LOS ANGELES, Oct. 3, 2005 (PRIMEZONE) -- Key executives and spokespersons from emerging growth smallcap companies Biophan Technologies (OTC BB:BIPH.OB - News), MIV Therapeutics (OTC BB:MIVT.OB - News) and Xenomics (OTC BB:XNOM.OB - News) will present strategic overviews and other investor-specific background in an online webcast of Trilogy Capital Partners' Biotechnology Forum, scheduled to start at 12 noon Eastern, October 11, 2005.
The Forum will also feature a keynote address from Dan D'Agostino, an investment banker who has specialized in the biotechnology sector for approximately 20 years. His address will focus on the current climate for biotechnology investment, including an analysis of sector performance during the second and third quarter of 2005. The conference will also feature brief comments by Paul Karon, President of Trilogy Capital Partners.

The webcast will last approximately 30 minutes. To view the conference, register online as explained below. There is no charge to register or watch the Forum. Conference and webcast information is as follows:


What: This live over-the-Internet video presentation employs a
fast-moving, informative format. It features on-camera
presentations by CEOs and company presenters, with
informational slides.

Who: Conference Moderator: Paul Karon, President -- Trilogy
Capital Partners, Inc. Keynote Speaker: Dan Dagastino.
Participating companies: MIV Therapeutics (OTC BB:MIVT.OB - News),
Xenomics (OTC BB:XNOM.OB - News) and Biophan Technologies
(OTC BB:BIPH.OB - News) will participate.

When: Tues, October 11, 2005, at 12 noon Eastern.

Where: Please register at http://www.trilogy-capital.com. Simply log on
a few minutes before the start of the Forum and you will
be able to view the webcast. Refresh your browser if
video fails to initiate or viewing difficulties occur.

Cost: The conference is free of charge and open to all
interested investors.

Archive: If you are unable to view the initial webcast, the
Forum will be archived for replay at
http://www.trilogy-capital.com.

Contact: Paul Karon at [phone] or
[e-mail].